
NouBio makes cell-based biomanufacturing commercially viable by cutting production costs and removing reliance on animal serum. The company combines a Bio-Intelligent Manufacturing platform with animal-free serum replacements, biodegradable microcarriers, AI-driven process tools, and robotic cellular farming to scale cell-based foods, biologics, and therapies. Its solutions include a market-validated serum alternative (NouSerum), patent-pending products, and planned GMP product launches and robotic biocomputers to move processes from lab to industrial scale. NouBio primarily serves food-technology and biomanufacturing customers aiming to lower unit economics and accelerate industrial adoption of cell-based production.

NouBio makes cell-based biomanufacturing commercially viable by cutting production costs and removing reliance on animal serum. The company combines a Bio-Intelligent Manufacturing platform with animal-free serum replacements, biodegradable microcarriers, AI-driven process tools, and robotic cellular farming to scale cell-based foods, biologics, and therapies. Its solutions include a market-validated serum alternative (NouSerum), patent-pending products, and planned GMP product launches and robotic biocomputers to move processes from lab to industrial scale. NouBio primarily serves food-technology and biomanufacturing customers aiming to lower unit economics and accelerate industrial adoption of cell-based production.
Headquarters: Los Angeles, California, USA
Core focus: Animal-serum replacements to lower cell-based biomanufacturing costs
Flagship product: NouSerum — a powdered FBS replacement (beta)
Cost claim: Aims to reduce cell-based biomanufacturing costs by up to 95%
Funding: Seed round: $200,000 (Nov 2022) — Big Idea Ventures
Cell‑based biomanufacturing inputs and scale‑up (animal serum replacement for cell culture).
Biotechnology
$200,000
“Big Idea Ventures (investor)”